Product Information
NORTRIPTYLINE HCL 75 MG CAP is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.2550 per EA under NDC 51672400401. Its NADAC has been published 515 times since Apr 13, 2016.
FDA first approved this application on May 8, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672400401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
NORTRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075520FDA Approved
5/8/2000
TE Code
AB
On Market Since
5/8/2000
Pharmacological Classes
Price Statistics
The NADAC for NORTRIPTYLINE HCL 75 MG CAP has been published 515 times since Apr 13, 2016, and over the history we have for it it has risen 26.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2550 per EA |
|---|---|
| All-time high | $0.3188 (Nov 12, 2025) |
| All-time low | $0.1260 (May 22, 2024) |
| 52-week high | $0.3188 |
| 52-week low | $0.2550 |
| Median price | $0.1909 |
| Average price | $0.1981 |
| Largest weekly change | +29.0% (Aug 23, 2017) |
| Weeks tracked | 515 |
| Tracking since | Apr 13, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-10.6%
3Y
+49.4%
5Y
+49.0%
All
+26.2%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NORTRIPTYLINE HCL 75 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for NORTRIPTYLINE HCL 75 MG CAP, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.2550 per EA (NDC 51672400401), effective Feb 18, 2026.
How has the price of NORTRIPTYLINE HCL 75 MG CAP changed over time?
Over the history we have for it, the NADAC for NORTRIPTYLINE HCL 75 MG CAP has risen 26.2%. It has been tracked across 515 weekly CMS publications since Apr 13, 2016.
What are the highest and lowest recorded NADAC prices for NORTRIPTYLINE HCL 75 MG CAP?
Since Apr 13, 2016, the NADAC for NORTRIPTYLINE HCL 75 MG CAP has ranged from a low of $0.1260 (May 22, 2024) to a high of $0.3188 (Nov 12, 2025), with a median of $0.1909 per EA.
Are there cheaper alternatives to NORTRIPTYLINE HCL 75 MG CAP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NORTRIPTYLINE HCL 75 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures NORTRIPTYLINE HCL 75 MG CAP?
NORTRIPTYLINE HCL 75 MG CAP (NDC 51672400401) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.